Report of Chronic Myeloid Leukemia in Chronic Phase from Omega Hospital and Indo-American Centre, Hyderabad, 2004-2010
Overview
Overview
Journal
Indian J Med Paediatr Oncol
Publisher
Thieme
Specialty
Oncology
Date
2014 Feb 12
PMID
24516311
Citations
1
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Omega hospital and Indo-American Center from Hyderabad presented a data of 55 patients with chronic myeloid leukemia 87% (48) patients were in chronic phase. 5% (3) patients had primary resistance, while 64% (36) had shown good response to imatinib. At a median follow-up of 36 months 73% (40) of patients were in chronic phase.
Citing Articles
Summary of the published Indian data on chronic myeloid leukemia.
Singhal M, Sengar M, Nair R South Asian J Cancer. 2016; 5(3):162-5.
PMID: 27606306 PMC: 4991141. DOI: 10.4103/2278-330X.187593.
References
1.
Hochhaus A, OBrien S, Guilhot F, Druker B, Branford S, Foroni L
. Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia. 2009; 23(6):1054-61.
DOI: 10.1038/leu.2009.38.
View
2.
Milojkovic D, Apperley J
. Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia. Clin Cancer Res. 2009; 15(24):7519-7527.
DOI: 10.1158/1078-0432.CCR-09-1068.
View